Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
26 Décembre 2024 - 10:29PM
Edgar (US Regulatory)
EXHIBIT 99.1
JOINT FILING AGREEMENT
We, the undersigned, hereby express our agreement that the attached Schedule 13G (or any amendments thereto) relating to the Common Stock of Mersana Therapeutics, Inc. is filed on behalf of each of us.
Dated: December 26, 2024
Nextech Crossover I SCSp
By:
Nextech Crossover I GP S.à r.l.
its
General Partner
By:
/s/ Ian Charoub
Name: Ian Charoub
Title: Manager
By:
/s/ Costas Constantinides
Name: Costas Constantinides
Title: Manager
Nextech Crossover I GP S.à r.l.
By:
/s/ Ian Charoub
Name: Ian Charoub
Title: Manager
By:
/s/ Costas Constantinides
Name: Costas Constantinides
Title: Manager
/s/ Ian Charoub
Ian Charoub
/s/ Costas Constantinides
Costas Constantinides
/s/ Rocco Sgobbo
Rocco Sgobbo
Mersana Therapeutics (NASDAQ:MRSN)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Mersana Therapeutics (NASDAQ:MRSN)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024